Trials / Unknown
UnknownNCT03350412
Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical Trials
Multiplex Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical Trials
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Fondazione del Piemonte per l'Oncologia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of delivering the right drug to the right cancer patient (precision medicine) requires a detailed understanding of how genomic alterations are linked to drug response. The purpose of this study is to intercept at point-of-care a large cohort of newly diagnosed mCRC patients to determine if it is possible to obtain personalized genetic information from each subject's tumor (tissue and blood) to triage treatment choices. In case of target positivity, patients will be conveyed, whenever possible, to self-standing, independent, hypothesis-driven POC trials as soon as they exhibit resistance to standard of care treatment.
Conditions
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2018-12-01
- Completion
- 2019-12-01
- First posted
- 2017-11-22
- Last updated
- 2018-10-30
Locations
5 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT03350412. Inclusion in this directory is not an endorsement.